Exchange: NASDAQ·Updated 08:03 AM EDT
EDSA logo

EDSA Edesa Biotech Inc

$4.62
$0.00
(0.00%)
Pre-Market
Prev Close $4.62
Mkt Cap$62.42M
Vol474.00

About EDSA

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
49

Neutral Sentiment

How do you feel about EDSA?

Advertisement|Remove ads.